Pharma & Biotech VC & Investment News
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Today's issue
Refine Search
Pharmaceutical
UCB and a syndicate of Belgian and international investors have founded a new firm, Syndesi Therapeutics, to be based at the Centre d’Entreprises et d’Innovation (CEI) in Louvain-la-Neuve, Belgium. 1 February 2018
Pharmaceutical
Boston, USA-based cancer company Partner Therapeutics (PTx) has acquired the global rights to develop, manufacture, and commercialize Leukine (sargramostim) from French pharma major Sanofi (Euronext: SAN). 1 February 2018
Biotechnology
The Bonn, Germany-based Life Science Inkubator is bringing to life a previously axed research project originating at Merck KGaA. 1 February 2018
Pharmaceutical
China’s Food and Drug Administration recently issued many new polices to push healthcare reform and drug innovation in the country. One of them is to acknowledge foreign trial data and hire more staff to speed up Investigational New Drug (IND) and New Drug Applications (NDA) approval, writes The Pharma Letter’s China correspondent Wang Fangqing. 29 January 2018
Biotechnology
Poland’s leading biotech firm Selvita has confirmed its intention to conduct a secondary public offering. 26 January 2018
Biotechnology
The UK has the strongest clinical and pre-clinical pipeline in Europe, according to a new report released on Thursday. 25 January 2018
Biotechnology
If the $100 million total raised by Tmunity Therapeutics in a Series A financing is not evidence enough that it could be a significant mover in the T-cell immunotherapies space, then the clout of its investors should be a definite clue. 24 January 2018
Biotechnology
Oxford University spinout Vaccitech has completed a series A financing round, securing £20 million ($27 million) in new money from Google’s venture capital arm GV, Sequoia China, and existing backer Oxford Sciences Innovation. 16 January 2018
Biotechnology
In what has been a very busy start to the year for biotech fundraising, arguably the most eye-catching of them all has been the $270 million Series A financing completed by BioNTech. 4 January 2018
Biotechnology
Expansion Therapeutics, a new 5AM Ventures formed private company focused on the discovery and development of ribonucleic acid (RNA) targeted small molecule medicines, announced today the close of a $55.3 million Series A financing. 4 January 2018
Pharmaceutical
German pharma major Boehringer Ingelheim has increased the size of its corporate venture fund to 250 million euros ($301 million). 3 January 2018
Biotechnology
Promore Pharma, a Swedish developer of therapeutic peptides, is to go on with efforts to fund a Phase III trial of PXL01 in North America – even if that means doing so alone. 2 January 2018
Pharmaceutical
The overall performance of Indian pharmaceutical companies on stock markets remained significantly under pressure during the full year 2017 on account of single digit growth in top line as well as bottom line, US Food and Drug Administration actions against major Indian pharma companies in respect of quality, demonetization, GST [tax] implementation and price cuts. 2 January 2018
Pharmaceutical
2017 ended with a couple of significant acquisitions stories: Roche’s $1.7 billion deal to buy Ignyta and Mallinckrodt’s $1.2 billion purchase of Sucampo Pharmaceuticals. There was also a flurry of year-end activity from the US Food and Drug Administration, which granted early approval for Aerie Pharmaceuticals’ glaucoma drug Rhopressa, as well as approvals for Exelixis’ cabozantinib and for Merck & Co and Pfizer’s Steglatro. Also attracting attention was Orchard Therapeutics’ fund raising. 31 December 2017
Pharmaceutical
Anglo-Swedish pharma major AstraZeneca saw its shares rise 2.39% to £51.18 on the news today that it has sold a batch of drug rights to the USA’s ANI Pharmaceuticals. 29 December 2017
Biotechnology
Biotech startup Clover Biopharmaceuticals has completed a 62.8 million renminbi ($9.5 million) series A financing round aimed at launching two compounds into human clinical trials next year. 19 December 2017
Biotechnology
A newly-formed biotechnology company in the Netherlands is the latest to chase the fast-growing, but elusive, market for the treatment of non-alcoholic steatohepatitis (NASH), where many products are under development, but none yet approved. 12 December 2017
Pharmaceutical
The upward momentum seen in the pharma and biotech sectors during 2017 looks set to continue into 2018, with more novel medicines set to hit the market and investor support for the industry remaining strong. 7 December 2017
Pharmaceutical
On Thursday, The Pharma Letter reported that privately-held biotech startup Immunochina had become the latest Chinese venture to attract overseas investment as it raised 50 million renminbi ($7.5 million) in a funding round. 24 November 2017
Biotechnology
Privately-held Chinese biotech startup Immunochina has raised 50 million renminbi ($7.5 million) in a funding round. 23 November 2017
Biotechnology
California-based venture capital firm Versant Ventures yesterday announced the launch of Pep2Tango Therapeutics, a start-up focused on innovative, next-generation weight loss therapies. Proceeds from the significant, undisclosed round will support development of the company’s novel unimolecular tetra-receptor agonist peptides to treat obesity and related conditions. 22 November 2024
Biotechnology
Hong Kong-based Sino Biopharm has signed an equity investment and strategic collaboration agreement with LaNova Medicines, advancing its oncology focus. 22 November 2024
Biotechnology
Colorado, USA-based biotech Enveda Biosciences, which is using AI to translate nature into new medicines, has announced an oversubscribed $130 million Series C funding round led by Kinnevik and FPV. 22 November 2024
Biotechnology
San Diego-based Cidara Therapeutics, a biotech using its proprietary Cloudbreak platform to develop drug-Fc conjugate (DFC) immunotherapies designed to save lives and improve the standard of care for patients facing serious diseases, has entered into a securities purchase agreement with certain investors to raise up to around $105 million. 21 November 2024
Biotechnology
Aizen Therapeutics, an AI-driven biotech headquartered in San Diego, has officially launched from stealth mode, introducing its drug discovery platform, DaX. 21 November 2024
Biotechnology
San Diego-based Valora Therapeutics, a biotech that boasts of having a novel approach to immunotherapy, has announced the successful closing of a $30 million seed funding round. 21 November 2024
article
The UK government has reappointed BioIndustry Association (BIA) chairman Daniel Mahony as its Life Sciences Investment Envoy. 21 November 2024
Pharmaceutical
Shanghai-based Leading Tac Pharmaceutical has announced the successful completion of a series A financing round, raising over 100 million yuan ($14 million). 21 November 2024
Biotechnology
A pair of industry veterans have teamed up to create Jupiter Bioventures, a San Francisco-based biotech venture foundry promised to build bold, science-driven therapeutics companies. 20 November 2024
Biotechnology
Aclaris Therapeutics has announced an exclusive licensing agreement with Biosion for broad rights to two new antibodies. 19 November 2024
Biotechnology
Californian oncology-focused biotech Avenzo Therapeutics has announced a pair of important updates. 19 November 2024
Pharmaceutical
In yet another sign of the mounting interest in radiopharmaceuticals, Tongrui Biopharma, a Chinese innovator in this area, has announced the completion of a $100 million series A+ financing round. 18 November 2024
Biotechnology
Shanghai-based biopharma Zai Lab has announced the pricing of its underwritten public offering at $25.50 per share, aiming to raise around $200 million. 15 November 2024
Pharmaceutical
New York-based Metsera, a biopharma developing medicines for obesity and metabolic diseases, has closed a $215 million Series B financing to further advance its portfolio of clinical-stage, nutrient-stimulated hormone (NuSH) analog peptides. 14 November 2024
Pharmaceutical
Life science investor Syncona has announced the launch of its newest portfolio company, Slingshot Therapeutics, through the Syncona Accelerator initiative. 14 November 2024
Biotechnology
Danish life sciences investor Novo Holdings is continuing the spread of its cash pile, this time as co-leader of a $181.4 million Series D financing in Alentis Therapeutics. 12 November 2024
Biotechnology
Trace Neuroscience, a newly launched biopharma based in San Francisco, aims to advance treatments for neurodegenerative diseases, starting with amyotrophic lateral sclerosis (ALS). 12 November 2024
Biotechnology
Geron Corporation, a biopharma company focused on telomerase inhibition therapies, has announced a $375 million financing agreement aimed at supporting the commercial rollout of Rytelo (imetelstat). 11 November 2024
Biotechnology
An Expert View from Cumulus Oncology about its innovative business model, which is all about improving the efficiency of drug R&D. 11 November 2024
Biotechnology
US biotech venture fund Aditum Bio and China’s Leads Biolabs today announced the formation of Oblenio Bio, marking the thirteenth company launched by Aditum. 7 November 2024
Sign up to receive email updates
Join industry leaders for a daily roundup of biotech & pharma news
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze